Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Working memory load improves diagnostic performance of smooth pursuit eye movement in mild traumatic brain injury patients with protracted recovery.

Stubbs JL, Corrow SL, Kiang BR, Corrow JC, Pearce HL, Cheng AY, Barton JJS, Panenka WJ.

Sci Rep. 2019 Jan 22;9(1):291. doi: 10.1038/s41598-018-36286-3.

2.

Extracellular Antibody Drug Conjugates Exploiting the Proximity of Two Proteins.

Marshall DJ, Harried SS, Murphy JL, Hall CA, Shekhani MS, Pain C, Lyons CA, Chillemi A, Malavasi F, Pearce HL, Thorson JS, Prudent JR.

Mol Ther. 2016 Oct;24(10):1760-1770. doi: 10.1038/mt.2016.119. Epub 2016 Jun 24.

3.

Prenatal domoic acid exposure disrupts mouse pro-social behavior and functional connectivity MRI.

Mills BD, Pearce HL, Khan O, Jarrett BR, Fair DA, Lahvis GP.

Behav Brain Res. 2016 Jul 15;308:14-23. doi: 10.1016/j.bbr.2016.03.039. Epub 2016 Apr 2.

4.

Fetal domoic acid exposure affects lateral amygdala neurons, diminishes social investigation and alters sensory-motor gating.

Zuloaga DG, Lahvis GP, Mills B, Pearce HL, Turner J, Raber J.

Neurotoxicology. 2016 Mar;53:132-140. doi: 10.1016/j.neuro.2016.01.007. Epub 2016 Jan 18.

5.

Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study.

Weich S, Pearce HL, Croft P, Singh S, Crome I, Bashford J, Frisher M.

BMJ. 2014 Mar 19;348:g1996. doi: 10.1136/bmj.g1996.

6.
7.

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.

Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL Jr, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK; AACR Task Force on Cancer Prevention.

Clin Cancer Res. 2006 Jun 15;12(12):3661-97. Review.

8.

The evolution of cancer research and drug discovery at Lilly Research Laboratories.

Pearce HL, Alice Miller M.

Adv Enzyme Regul. 2005;45:229-55. Epub 2005 Sep 6.

PMID:
16143373
9.

Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs.

Kelloff GJ, Schilsky RL, Alberts DS, Day RW, Guyton KZ, Pearce HL, Peck JC, Phillips R, Sigman CC.

Clin Cancer Res. 2004 Jun 1;10(11):3908-18. Review. No abstract available.

10.

Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.

Suh N, Glasebrook AL, Palkowitz AD, Bryant HU, Burris LL, Starling JJ, Pearce HL, Williams C, Peer C, Wang Y, Sporn MB.

Cancer Res. 2001 Dec 1;61(23):8412-5.

11.

Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.

Shepard RL, Winter MA, Hsaio SC, Pearce HL, Beck WT, Dantzig AH.

Biochem Pharmacol. 1998 Sep 15;56(6):719-27.

PMID:
9751076
12.

Preclinical, pharmacologic, and phase I studies of gemcitabine.

Storniolo AM, Allerheiligen SR, Pearce HL.

Semin Oncol. 1997 Apr;24(2 Suppl 7):S7-2-S7-7. Review.

PMID:
9194473
14.

Anticancer drug development at Lilly Research Laboratories.

Pearce HL.

Ann Oncol. 1995;6 Suppl 1:55-62. Review.

PMID:
8695546
15.

Clinical oncology and chemical thermodynamics.

Seitz DE, Pearce HL.

Cancer Invest. 1990;8(2):233-5.

PMID:
2400939
16.

Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance.

Pearce HL, Winter MA, Beck WT.

Adv Enzyme Regul. 1990;30:357-73.

PMID:
1976291
17.

Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.

Pearce HL, Safa AR, Bach NJ, Winter MA, Cirtain MC, Beck WT.

Proc Natl Acad Sci U S A. 1989 Jul;86(13):5128-32.

18.

Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols.

Seitz DE, Katterjohn CJ, Rinzel SM, Pearce HL.

Cancer Res. 1989 Jul 1;49(13):3525-8.

19.
20.

An instrument designed to help reduce and percutaneously pin fractured phalanges.

Blalock HS, Pearce HL, Kleinert H, Kutz J.

J Bone Joint Surg Am. 1975 Sep;57(6):792-4. No abstract available.

PMID:
1158916
21.

Teacher training: which way next?

McDonald L, Pearce HL, Radley R.

Spec Educ. 1971 Dec;60(4):6-9. No abstract available.

PMID:
5133740
22.

Surgical enucleation of circumscribed tylomata.

PEARCE HL.

J Natl Assoc Chirop. 1952 Jul;42(7):24-8. No abstract available.

PMID:
12991014
23.

Custom base shoes.

PEARCE HL.

J Natl Assoc Chirop. 1950 Apr;40(4):19-28. No abstract available.

PMID:
15412346

Supplemental Content

Loading ...
Support Center